Pandemic influenza remains a significant global health threat, as signalled by the circulation and cross-species transmission of avian influenza A(H5N1) viruses from the clade 2.3.4.4b, including ...

Prior exposures to specific types of seasonal influenza viruses promote cross-reactive immunity against the H5N1 avian ...

An in-house reverse-genetics generated H5N9 inactivated vaccine (SEP-22- N9) was evaluated for its vaccine efficacy in ...

There are two H5 vaccines that have been developed and approved for use in humans, Martinello says. While those vaccines aren't available right now, they could be shipped out within weeks, if needed, ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.

There are two H5 vaccines that have been developed and approved for use in humans, Martinello says. While those vaccines aren't available right now, they could be shipped out within weeks ...

VAXXITEK ® HVT+IBD+H5 is a new trivalent vaccine for poultry that offers protection against Marek’s disease, Infectious Bursal Disease and H5 avian influenza in just one shot. H5 avian ...

Launching this month, Vaxitek HVT+IBD+H5 integrates COBRA technology to address the ongoing viral evolution challenges of avian influenza, as well as for the prevention of Marek disease and infectious ...

No current vaccine meets the full criteria for deployment to tackle the UK's ongoing bird flu outbreak, the avian influenza ...

Farms must be allowed to vaccinate ahead of the winter, or South Africa’s industry risks losing half its flocks to avian ...